Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Feitosa, Alina C R ^a   Feitosa Filho, Gilson S ^a   Freitas, Fatima R ^a   Wajchenberg, Bernardo L ^a   Maranhão, Raul C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiovascular disease; Cholesterol metabolism; Glycemia; Insulin treatment; Lipids transfer; Lipoprotein; Type 1 diabetes mellitus

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL ESTERIFICATION; CLINICAL ARTICLE; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LIPOPROTEIN METABOLISM; MALE; NANOEMULSION;

ADULT; BLOOD GLUCOSE; CARBON RADIOISOTOPES; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 1; DISEASE MANAGEMENT; DRUG ADMINISTRATION SCHEDULE; DYSLIPIDEMIAS; FAT EMULSIONS, INTRAVENOUS; HALF-LIFE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; LIPID METABOLISM; MALE; TRIGLYCERIDES;

EID: 84873511357     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-15     Document Type: Article

References (42)

1. Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control study. Guy J, Ogden L, Wadwa RP, Hamman RF, Mayer-Davis EJ, Liese AD, Jr DAgostino R, Marcovina S, Dabelea D, Diabetes Care 2009 32 416 420 10.2337/dc08-1775 19092167
2. Low-density lipoprotein particle size and coronary artery disease in a childhood-onset type 1 diabetes population. Erbey JR, Robbins D, Forrest KY, Orchard TJ, Metabolism 1999 48 531 534 10.1016/S0026-0495(99)90116-6 10206450 (Pubitemid 29174236)
3. Lipoprotein compositional abnormalities in type I diabetes: effect of improved glycaemic control. Perez A, Caixas A, Carreras G, Mauricio D, Pou JM, Serrat J, Gómez-Gerique J, de Leiva A, Diabetes Res Clin Pract 1997 36 83 90 10.1016/S0168-8227(97)00033-8 9229192 (Pubitemid 27297001)
4. Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. Bagdade JD, Ritter MC, Subbaiah PV, Eur J Clin Invest 1991 21 161 167 10.1111/j.1365-2362.1991.tb01805.x 1905628
5. Metabolic behavior in rats of a non protein microemulsion resembling low-density lipoprotein. Maranhao RC, Cesar TB, Pedroso-Mariani SR, Hirata MH, Mesquita CH, Lipids 1993 28 691 696 10.1007/BF02535988 8377582 (Pubitemid 23241433)
6. Plasma kinetics and biodistribution of a lipid emulsion resembling low-density lipoprotein in patients with acute leukemia. Maranhao RC, Garicochea B, Silva EL, Dorlhiac-Llacer P, Cadena SM, Coelho IJ, Meneghetti JC, Pileggi FJ, Chamone DA, Cancer Res 1994 54 4660 4666 8062260
7. Plasma kinetic behavior in hyperlipidemic subjects of a lipidic microemulsion that binds to low density lipoprotein receptors. Maranhao RC, Roland IA, Toffoletto O, Ramires JA, Gonçalves RP, Mesquita CH, Pileggi F, Lipids 1997 32 627 633 10.1007/s11745-997-0080-6 9208392 (Pubitemid 27278574)
8. Effects of apolipoprotein B-100 on the metabolism of a lipid microemulsion model in rats. Hirata RD, Hirata MH, Mesquita CH, Cesar TB, Maranhao RC, Biochim Biophys Acta 1999 1437 53 62 10.1016/S1388-1981(98)00004-3 9931432 (Pubitemid 29242903)
9. Plasma kinetics of free and esterified cholesterol in familial hypercholesterolemia: effects of simvastatin. Santos RD, Chacra AP, Morikawa A, Vinagre CC, Maranhao RC, Lipids 2005 40 737 743 10.1007/s11745-005-1437-6 16196425 (Pubitemid 41266313)
10. In vitro simultaneous transfer of lipids to HDL in coronary artery disease and in statin treatment. Lo Prete AC, Dina CH, Azevedo CH, Puk CG, Lopes NH, Hueb WA, Maranhão RC, Lipids 2009 44 917 924 10.1007/s11745-009-3342- 2 19760244
11. Lecithin cholesterol acyltransferase. Jonas A, Biochim Biophys Acta 2000 1529 245 256 10.1016/S1388-1981(00)00153-0 11111093
12. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group, N Engl J Med 2005 353 2643 2653 16371630 (Pubitemid 41817713)
13. Effects of insulin treatment on lipoprotein composition and function in patients with IDDM. Bagdade JD, Dunn FL, Diabetes 1992 41 107 110 10.2337/diabetes.41.1.107 1526328
14. Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus. Bagdade JD, Dunn FL, Eckel RH, Ritter MC, ArteriosclerThromb 1994 14 1933 1939 10.1161/01.ATV.14.12.1933
15. Effect of intensive diabetes treatment on low-density lipoprotein apolipoprotein B kinetics in type I diabetes. Rosenstock J, Vega GL, Raskin P, Diabetes 1988 37 393 397 10.2337/diabetes.37.4.393 3288528 (Pubitemid 18096374)
16. Enhanced removal from the plasma of LDL-like nanoemulsion cholesteryl ester in trained men compared with sedentary healthy men. Vinagre CG, Ficker ES, Finazzo C, Alves MJ, de Angelis K, Irigoyen MC, Negrão CE, Maranhão RC, J Appl Physiol 2007 103 1166 1171 10.1152/japplphysiol.01176.2006 17626830 (Pubitemid 47605950)
17. Oxidative modification of LDL and atherogenesis. Steinberg D, Lewis A, Conner Memorial Lecture, Circulation 1997 95 1062 1071 10.1161/01.CIR.95.4.1062 9054771
18. Receptor-mediated mechanisms of lipoprotein remnant catabolism. Chappell DA, Medh JD, Prog Lipid Res 1998 37 393 422 10.1016/S0163-7827(98)00017-4 10209655 (Pubitemid 28475003)
19. Cell surface expression of LDL receptor is decreased in type 2 diabetic patients and is normalized by insulin therapy. Duvillard L, Florentin E, Lizard G, Petit JM, Galland F, Monier S, Gambert P, Vergès B, Diabetes Care 2003 26 1540 1544 10.2337/diacare.26.5.1540 12716819 (Pubitemid 36929193)
20. Glucose transport: pivotal step in insulin action. Kahn BB, Lilly lecture 1995, Diabetes 1996 45 1644 1654 10.2337/diabetes.45.11.1644 8866574 (Pubitemid 26357562)
21. Insulins direct effects on the liver dominate the control of hepatic glucose production. Edgerton DS, Lautz M, Scott M, Everett CA, Stettler KM, Neal DW, Chu CA, Cherrington AD, J Clin Invest 2006 116 521 527 10.1172/JCI27073 16453026 (Pubitemid 43228370)
22. Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans. Farese RV Jr, Yost TJ, Eckel RH, Metabolism 1991 40 214 216 10.1016/0026-0495(91)90178-Y 1988780
23. Hormonal regulation of hormone-sensitive lipase in intact adipocytes: identification of phosphorylated sites and effects on the phosphorylation by lipolytic hormones and insulin. Stralfors P, Bjorgell P, Belfrage P, Proc Natl Acad Sci USA 1984 81 3317 3321 10.1073/pnas.81.11.3317 6374655 (Pubitemid 14123429)
24. Normal insulin secretion: the goal of artificial insulin delivery systems? Eaton RP, Allen RC, Schade DS, Standefer JC, Diabetes Care 1980 3 270 273 10.2337/diacare.3.2.270 6993139 (Pubitemid 10078123)
25. Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus. Duvillard L, Pont F, Florentin E, Gambert P, Vergès B, Diabetologia 2000 43 27 35 10.1007/s001250050004 10990093 (Pubitemid 30129299)
26. Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease. Santos RD, Hueb W, Oliveira AA, Ramires JA, Maranhao RC, J Lipid Res 2003 44 464 469 10.1194/jlr.M200331-JLR200 12562871 (Pubitemid 37279693)
27. Cholesteryl ester transfer and cholesterol esterification in type 1 diabetes: relationships with plasma glucose. Chang CK, Tso TK, Snook JT, Huang YS, Lozano RA, Zipf WB, Acta Diabetol 2001 38 37 42 10.1007/s005920170027 11487175 (Pubitemid 32758292)
28. Lipid transfers to HDL are predictors of precocious clinical coronary heart disease. Maranhao RC, Freitas FR, Strunz CM, Santos RD, Mansur AJ, Mansur AP, Clin Chim Acta 2012 413 502 505 10.1016/j.cca.2011.11.011 22120728
29. Metabolism of triglyceride-rich lipoproteins and lipid transfer to high-density lipoprotein in young obese and normal-weight patients with polycystic ovary syndrome. Rocha MP, Maranhao RC, Seydell TM, Barcellos CR, Baracat EC, Hayashida SA, Bydlowski SP, Marcondes JA, Fertil Steril 2010 93 6 1948 1956 10.1016/j.fertnstert.2008.12.044 19765700
30. Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus-its relationship with serum lipids. Dullaart RP, Groener JE, Dikkeschei LD, Erkelens DW, Doorenbos H, Diabetologia 1989 32 14 19 2707515 (Pubitemid 19061736)
31. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The care investigators. Goldberg RB, Mellies MJ, Sacks FM, Goldberg RB, Mellies MJ, Sacks FM, Moyé LA, Howard BV, Howard WJ, Davis BR, Cole TG, Pfeffer MA, Braunwald E, Circulation 1998 98 2513 2519 10.1161/01.CIR.98.23.2513 9843456 (Pubitemid 29001188)
32. Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus. Kissebah AH, Alfarsi S, Evans DJ, Adams PW, J Clin Invest 1983 71 655 667 10.1172/JCI110812 6338042 (Pubitemid 13160813)
33. Low density lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Kissebah AH, Diabetes Metab Rev 1987 3 619 651 10.1002/dmr.5610030302 3301236 (Pubitemid 17112105)
34. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, ADVANCE Collaborative Group, N Engl J Med 2008 12 2560 2572 (Pubitemid 351831357)
35. Glucose control and vascular complications in veterans with type 2 diabetes. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD, VADT Investigators, N Engl J Med 2009 8 360 129-39
36. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group, N Engl J Med 2005 22 353 2643-53
37. Long-term follow-up after tight control of blood pressure in type 2 diabetes. Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR, N Engl J Med 2008 9 359 1565-76
38. Can clinical factors estimate insulin resistance in type 1 diabetes? Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ, Diabetes 2000 49 626 632 10.2337/diabetes.49.4.626 10871201 (Pubitemid 30183752)
39. Comparison of hemoglobin A1c and hemoglobin A1 in diabetic patients. James TM, Davis JE, McDonald JM, Santiago JV, Ladenson JH, Clin Biochem 1981 14 25 27 10.1016/0009-9120(81)90135-1 7237739 (Pubitemid 12176589)
40. Deposition of free cholesterol in the blood vessels of patients with coronary arterydisease: a possible novel mechanism for atherogenesis. Couto RD, Dallan LA, Lisboa LA, Mesquita CH, Vinagre CG, Maranhão RC, Lipids 2007 42 411 418 10.1007/s11745-007-3041-9 17443358 (Pubitemid 46870359)
41. Resistance training changes LDL metabolism in normolipidemic subjects: a study with a nanoemulsion mimetic of LDL. da Silva JL, Vinagre CG, Morikawa AT, Alves MJ, Mesquita CH, Maranhão RC, Atherosclerosis 2011 219 2 532 537 10.1016/j.atherosclerosis.2011.08.014 21906740
42. Radiation protection. Sowby FS, Limits for Intakes of Radionuclides by Workers Oxford: ICRP publication 30. Part I. Pergamon 1984